Sidley advised I-Mab on the deal. I-Mab (Nasdaq: IMAB) obtained a victory in a multi-year long dispute over two collaboration agreements between I-Mab and Tracon Pharmaceuticals...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here